RFK Jr.'s nomination for Health Secretary sparks debate with Bernie Sanders over pharmaceutical industry influence and healthcare reform.
Chevron's Q4 earnings fall short due to refining loss, but the company continues strategic initiatives like a $53 billion Hess acquisition.
Fed Governor Bowman cautions against hasty rate cuts, citing elevated inflation risks and the need for more data confirmation before further policy adjustments.
RFK Jr.'s nomination for Health Secretary sparks debate with Bernie Sanders over pharmaceutical industry influence and healthcare reform.
Chevron's Q4 earnings fall short due to refining loss, but the company continues strategic initiatives like a $53 billion Hess acquisition.
Fed Governor Bowman cautions against hasty rate cuts, citing elevated inflation risks and the need for more data confirmation before further policy adjustments.